Supernus Pharmaceuticals
SUPN
#4494
Rank
โ‚ฌ2.21 B
Marketcap
38,08ย โ‚ฌ
Share price
1.26%
Change (1 day)
-9.84%
Change (1 year)

Market capitalization of Supernus Pharmaceuticals (SUPN)

Market cap: โ‚ฌ2.21 Billion

As of October 2026 Supernus Pharmaceuticals has a market cap of โ‚ฌ2.21 Billion. This makes Supernus Pharmaceuticals the world's 4494th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Supernus Pharmaceuticals from 2012 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚ฌ2.21 B-11.92%
2025โ‚ฌ2.51 B27.59%
2024โ‚ฌ1.97 B37.94%
2023โ‚ฌ1.43 B-20.44%
2022โ‚ฌ1.79 B31.28%
2021โ‚ฌ1.36 B26.62%
2020โ‚ฌ1.08 B-2.78%
2019โ‚ฌ1.11 B-26.78%
2018โ‚ฌ1.51 B-10.77%
2017โ‚ฌ1.70 B43.17%
2016โ‚ฌ1.18 B97.42%
2015โ‚ฌ0.60 B105.39%
2014โ‚ฌ0.29 B34.35%
2013โ‚ฌ0.21 B31.52%
2012โ‚ฌ0.16 B

End of Day market cap according to different sources

On Oct 10th, 2026 the market cap of Supernus Pharmaceuticals was reported to be:

โ‚ฌ2.21 Billion
by Nasdaq info icon info icon
โ‚ฌ2.21 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ562.25 B 25,259.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
โ‚ฌ154.81 B 6,882.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚ฌ938.04 B 42,209.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ107.77 B 4,760.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Zogenix
ZGNX
โ‚ฌ1.33 B-39.62%๐Ÿ‡บ๐Ÿ‡ธ USA
United Therapeutics
UTHR
โ‚ฌ21.01 B 848.06%๐Ÿ‡บ๐Ÿ‡ธ USA